HTG Molecular Diagnostics, Inc.
HTGM · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $4 | $4 | $5 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $4 | $4 | $5 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -28.5% | 4.2% | -55.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 28.2% | 54% | 53.3% | 53.6% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -316.4% | -219.6% | -210.1% | -86.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -339.2% | -192.5% | -244.1% | -100.5% |
| EPS Diluted | -0.24 | -0.3 | -0.32 | -0.5 |
| % Growth | 20% | 6.3% | 36% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |